摘要
目的将沐舒坦和高渗盐水联合用药,对29例无痰或少痰的肺部疾病患者,使用诱导法增加痰量,观察排痰效果,判断该方法的安全性。方法所有入选患者在固定的时间内雾化吸入沐舒坦和高渗盐水,刺激咳嗽并留取痰液,在诱导前后做心率(HR)、呼吸(RR)、血氧饱和度(Sao2)、一秒最大呼气量(FEV1)的监测。结果29例患者全部成功获取痰液,诱导前后心率,呼吸、血氧饱和、一秒最大呼气量无显著变化(P>0.05)。结论对无痰或少痰的肺部疾病患者,沐舒坦与高渗盐水联合用药雾化吸入诱导排痰是一种安全有效地留取痰液的方法。
Objective Application musocolvan and hypertonic saline solution together, for 29 case pneumopathy patients with no sputum or with little sputum, induction method were used to increase sputum, expectoration effect were observed and safety were judjed. Methods The selected patients aerosol inhale musocolvan and hypertonic saline solution together, sputum were collected, HR,RR,Sao2 and FEV1were monitored post inducting. Results All 29 case patients collected sputum well, HR,RR,Sao2 and FEV1 have no significant change before and after inducting(p>0.05). Conlusion For pneumopathy patients with no sputum or with little sputum, musocolvan and hypertonic saline solution together aerosol inhalation is a safety method for expectoration.
出处
《医学检验与临床》
2008年第5期53-54,52,共3页
Medical Laboratory Science and Clinics
关键词
肺疾病
盐水
高渗
休舒坦
安全
Pneumopathy
Saline solution
Hypertonic
Musocolvan
Safety
